GlobalFoundries Launches Quantum Technology Solutions Unit Backed by 375 Million CHIPS Award US Consumer Sensitivity to Rising Energy Costs May Shape Spending Patterns Tesla TSLA Remains a Core Holding for ARK Invest Analyzing the Potential Ebola Risk Elevated to Very High in DR Congo Potential Implications for Regional Economies and Investors Estate Planning Strategies for HighIncome Trusts Shifting Tax Burden to Beneficiaries Cricket Fandom Goes Digital Fan Tokens Could Be the Next Big Play in Sports Engagement First Financial Bancorp FFBC Q1 2026 Earnings Earnings Beat Expectations as Core Operations Hold Steady FATE Q1 2026 Earnings Narrows Loss Per Share Stock Rises on Improved Bottom Line SFL Q1 2026 Earnings Earnings Per Share Surges Past Estimates Stock Declines Despite Massive Beat High Templar Tech Limited HTT Q1 2023 Earnings Positive EPS Result Drives Sharp Stock Rally ReNew Energy Global plc RNW Q1 2026 Earnings EPS Surges Past Estimates as Profitability Improves Veracyte VCYT Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response American Homes 4 Rent AMH Slides Slightly Amidst Sector Headwinds Key Levels in Focus Hesai Group HSAI Slides 357 as Selling Pressure Intensifies Sharps Technology Inc Warrant STSSW Slides 765 as Support and Resistance Converge at 004 LightInTheBox LITB Surges 48 Testing Key Resistance at 275 as Volume Picks Up GAINZ Notes Hold Steady Near 2416 as Yield Appeal Balances Rate Headwinds Microsoft Appoints Jenny LayFlurrie to Lead Trusted Technology Amid AI Speed vs Responsibility Tensions SERV Q1 2026 Earnings EPS Misses on WiderThanExpected Loss Baozun Inc BZUN Dips 27 as Shares Approach Key Support Level ZK International Group ZKIN Drops 714 Key Levels Under Pressure Ares Commercial Real Estate ACRE Slides 2 as Commercial Real Estate Headwinds Persist GE HealthCare Technologies Inc GEHC Holds Steady Near Support as Sector Rotation Plays Out Kyverna Therapeutics KYTX Faces Resistance at 889 After Pulling Back to 847 Bayview Acquisition Corp BAYA Plunges 565 as SPAC Premium Shrinks Amid Deal Uncertainty Interactive Strength TRNR Rises 272 Testing NearTerm Resistance at 081 Akebia Therapeutics AKBA Holds Steady at 102 as Support and Resistance Levels Tighten